Skip to main content
Ramin Farzaneh-Far, MD, Cardiology, Dallas, TX

RaminFarzaneh-FarMD

Cardiology Dallas, TX

Adult Congenital Heart Disease

Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Are you Dr. Farzaneh-Far?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 49 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    Ut Southwestern Medical Ctr
    5323 Harry Hines Boulevard
    Dallas, TX 75390
    Phone+1 214-645-7500

Summary

  • Dr. Ramin Farzaneh-Far, MD is a cardiologist in Dallas, Texas. He is currently licensed to practice medicine in Texas and California. He is an Assistant Professor at University of Texas Southwestern Medical Center.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 2006 - 2009
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2005
  • Royal Free Hospital and University College London Medical School
    Royal Free Hospital and University College London Medical SchoolClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • TX State Medical License
    TX State Medical License 2011 - 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program
    Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 ProgramAugust 8th, 2018
  • Ra Pharmaceuticals Initiates Phase 1b Trial of New Therapy for Lupus Nephritis
    Ra Pharmaceuticals Initiates Phase 1b Trial of New Therapy for Lupus NephritisJanuary 9th, 2018